NEW YORK (GenomeWeb) – Fulgent Genetics this week said in a regulatory document that it has formed a joint venture in China to offer genetic testing services in that country.

In a document filed with the US Securities Exchange Commission, Fulgent said it has formed a joint venture with Chinese firms Xilong Scientific and Fuzhou Jinqiang Investment Partnership (FJIP) to establish Fujian Fujun Gene Biotech. Under the agreement Fulgent will provide to the JV genetic sequencing and other equipment costing no more than about RMB60 million ($8.7 million) over a three-year period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.